More on CBLI

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+94.7% Growth)
- Ratings (6.7 Score)
- Holders

Financials

Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- Earnings (8/12/16 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

CBLI Income Statement

Click line-items for a historical chart and %
REVENUES
Grant and contract
Sales Revenue, Net, Total
OPERATING EXPENSES
Research and development 1.9M
General and administrative
Total operating expenses 3.08M
LOSS FROM OPERATIONS -1.81M
OTHER (INCOME)/EXPENSE
Interest income
Other income
Other expense
Change in value of warrant liability
Total other (income)/expense 142.89K
NET INCOME/(LOSS) -1.67M
LOSS ATTRIBUTABLE TO NONCONTROLLING INTERESTS 246.2K
NET INCOME/(LOSS) ATTRIBUTABLE TO CLEVELAND BIOLABS, INC.
NET INCOME/(LOSS) AVAILABLE TO COMMON SHAREHOLDERS PER SHARE OF COMMON STOCK BASIC (in dollars per share)
NET INCOME/(LOSS) AVAILABLE TO COMMON SHAREHOLDERS PER SHARE OF COMMON STOCK DILUTED (in dollars per share)
WEIGHTED AVERAGE NUMBER OF SHARES USED IN CALCULATING NET INCOME/(LOSS) PER SHARE, BASIC (in shares)
WEIGHTED AVERAGE NUMBER OF SHARES USED IN CALCULATING NET INCOME/(LOSS) PER SHARE, DILUTED (in shares)